Evaluation of Predictive Factors for Recurrence of Persistent Atrial Fibrillation After Ablation

This is a single-center, retrospective, observational study based on data extracted from the medical records of patients who underwent a procedure for persistent atrial fibrillation ablation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Privé Clairval

Marseille, 13009, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient aged 18 years or older, who has been informed about the research
Patient who underwent a procedure for persistent atrial fibrillation ablation at Clairval Hospital since January 2014
Patient for whom data regarding the ablation procedure are available

Exclusion criteria

Patient under legal protection, guardianship, or conservatorship
Patient who has expressed opposition to the use of their medical data (by completing and returning the opt-out form provided)

Treatment and study plan

Atrial fibrillation ablation

Procedure

Persistent atrial fibrillation ablation

Primary outcomes

Recurrence of persistent atrial fibrillation

Time frame: Month 12

The main objective of the study is to assess to what extent patient characteristics and conditions during the atrial fibrillation ablation procedure can identify predictive factors for recurrence.

Recurrence (Yes/No) is the outcome variable to be explained.

Sponsors and collaborators

Lead sponsor

GCS Ramsay Santé pour l'Enseignement et la Recherche

Other

Registry information

Acronym: FAIR

Important dates

Study start: 2023
Primary completion: 2024
Study completion: 2024
First posted: Oct 1, 2024
Registry last updated: Oct 1, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed